Ireland· IE-PA-EU/1/19/1392/001
Ervebo solution for injection
A ebola-impfstoffe product containing recombinant vesicular stomatitis virus - zaire ebolavirus vaccine (live attenuated), registered in Ireland by Merck Sharp & Dohme BV,. The same ATC class is registered in 9 of our 19 countries.
Checked against HPRA (Ireland) on
Informational only — not a medical device.
Where it is registered
Ebola-impfstoffe is registered in 9 of 19 countries.
Countries holding a registration under ATC J07BX02 (ebola-impfstoffe), each read from that country’s own register.
- This record: Ireland, from HPRA (Ireland)
- 6 of them publish a price we can compare per daily dose
Ebola-impfstoffe · ATC J07BX02
9 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Polandprice
- Switzerlandprice
The record
At a glance
HPRA (Ireland)- Active substance
- Recombinant Vesicular Stomatitis Virus - Zaire Ebolavirus Vaccine (Live Attenuated)
- Manufacturer
- Merck Sharp & Dohme BV,
- Country
- Ireland (IE)
- ATC code
- J07BX02
- ATC class
- Ebola-Impfstoffe
- Reimbursed
- Not published by this register
- Source register
- HPRA (Ireland)
- Last checked
- September 28, 2026
Packs & prices · 1
- ie_pa_numberEU/1/19/1392/001
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same class
Other records under J07BX02
Ebola-impfstoffe, as other registers publish it.
- IcelandErveboMerck Sharp & Dohme B.V.*
- BelgiumErveboMerck Sharp & Dohme
- FinlandErveboMerck Sharp & Dohme B.V.
- PolandErveboMerck Sharp & Dohme B.V.
- DenmarkErveboMerck Sharp & Dohme B.V.
- CzechiaERVEBOMerck Sharp & Dohme B.V., Haarlem
- SwitzerlandErvebo, InjektionslösungMSD Merck Sharp & Dohme AG
- NetherlandsErvebo, oplossing voor injectieMerck Sharp & Dohme B.V.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of HPRA (Ireland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/21d005c6-75af-439b-a700-e4a7df75d559 GET /v1/drugs/21d005c6-75af-439b-a700-e4a7df75d559?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Solution for injection",
"routes": [
"Intramuscular use"
],
"source": "hpra",
"atc_all": [
"J07BX",
"J07BX02"
],
"strength": null,
"pa_number": "EU/1/19/1392/001",
"substances": [
"Recombinant Vesicular Stomatitis Virus - Zaire Ebolavirus Vaccine (Live Attenuated)"
],
"legal_basis": "Full application (Article 8(3) of Directive No 2001/83/EC)",
"market_info": "Unknown",
"authorised_at": "11/11/2019",
"dispensing_status": "Product subject to prescription which may not be renewed (A)",
"registration_status": "AU",
"supply_legal_status": "Supply through pharmacies only",
"interchangeable_code": null
}See everything about ebola-impfstoffe.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.